Verax gains support for work on blood bacteria screening

10/10/2013 | MedCityNews.com

Verax Biomedical has secured $12 million to expedite the development of an advanced version of its assay for detecting bacteria in red blood cells before transfusions. The test could have applications in cellular therapies as well, according to the company.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN